(Credit-Canva)
The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.
Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.
Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.
Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.
Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.
Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.
Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.
According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.
All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.
Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.
Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.
Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.
People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.
Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.
Credits: Canva
FDA refuses to review Moderna's flu vaccine: The U.S. Food and Drug Administration (FDA) has declined to begin reviewing Moderna’s application for its experimental flu vaccine. The company made the announcement on Tuesday. The decision marks another signal of stricter vaccine oversight under the Trump administration and has already rattled investor confidence, with Moderna’s stock falling nearly 7% in after-hours trading.
Read: CDC Vaccine Schedule: Coverage Falls From 17 to 11 Diseases For Children
Moderna said the FDA’s refusal came as a surprise and contradicted feedback the company had received earlier, before it submitted the application and launched phase three trials for the vaccine, known as mRNA-1010. The company has now requested a meeting with the agency to better understand what it described as an unclear “path forward.”
According to Moderna, the FDA did not flag any safety or efficacy concerns with the vaccine itself. Instead, the agency objected to the design of the clinical trial—despite having previously signed off on it. Moderna added that the setback would not affect its financial guidance for 2026.
The experimental flu shot had shown encouraging results in phase three trials last year, successfully meeting all primary trial endpoints. At the time, Moderna positioned the stand-alone flu vaccine as a critical step toward developing a combined influenza and COVID-19 vaccine, a key long-term goal for the company.
The decision comes amid sweeping changes to U.S. immunisation policy over the past year under Health and Human Services Secretary Robert F. Kennedy Jr., who has long expressed skepticism toward vaccines. Moderna on Tuesday pointed to the FDA’s top vaccine regulator, Vinay Prasad, who returned to the agency in August after being removed earlier.
Prasad currently heads the FDA’s Center for Biologics Evaluation and Research (CBER) and has publicly argued for tighter regulatory standards for vaccines. He has also drawn controversy for comments linking child deaths to COVID-19 vaccines.
In a letter dated February 3 and signed by Prasad, the FDA stated that its refusal to review Moderna’s application was solely due to concerns about the trial’s design. Specifically, the agency objected to Moderna’s choice of comparator, arguing that comparing the experimental shot to a standard, approved flu vaccine did not represent the “best available standard of care.”
As a result, the FDA concluded that the study did not qualify as an “adequate and well-controlled” trial under its regulatory definition.
Moderna has strongly disputed this interpretation, arguing that FDA rules do not require companies to use the most advanced or highest-dose vaccine as a comparator in clinical trials.
In a statement, Moderna CEO Stéphane Bancel said the decision undermines innovation and fails to advance shared public health goals. He emphasized that the trial design had been discussed and agreed upon with CBER before the study began.
Moderna now expects the earliest possible approval for its flu shot to come in late 2026 or 2027, pending regulatory reviews across the U.S., Europe, Canada, and Australia.
The FDA declined to comment, stating it does not discuss regulatory communications with individual companies, reported CNBC.
Credits: Canva
Mongolia is witnessing a sharp rise in measles infections, with the total number of confirmed cases reaching 14,123, according to the country’s National Centre for Communicable Diseases (NCCD). Health officials say the outbreak is largely affecting school-age children, many of whom had received only one dose of the measles vaccine instead of the recommended two.
In a public advisory, the NCCD urged parents to ensure their children complete the full vaccination schedule, warning that partial immunization leaves children vulnerable to a potentially severe and highly contagious disease.
Health authorities noted that the majority of new infections were recorded among children who had not received their second measles shot. While a single dose offers some protection, it is not sufficient to prevent outbreaks, especially in school settings where close contact accelerates transmission.
The NCCD stressed that completing the two-dose regimen significantly strengthens immunity and reduces the risk of community-wide spread.
Measles is considered one of the most infectious diseases known to humans. It spreads through direct contact with infected nasal or throat secretions, such as coughing or sneezing, and through airborne transmission in enclosed spaces.
What makes measles particularly dangerous is its ability to remain active in the air or on surfaces for up to two hours after an infected person has left the area. According to health experts, a single measles patient can infect up to 18 other people, making rapid containment extremely challenging once outbreaks begin.
Vaccination remains the most effective way to prevent measles infection and limit its spread. The measles vaccine is safe, cost-effective and helps the immune system recognize and fight the virus before serious illness develops.
Before the measles vaccine was introduced in 1963 and widely adopted, large-scale outbreaks occurred every two to three years worldwide, causing an estimated 2.6 million deaths annually. Despite medical advances, measles continues to claim lives when vaccination coverage declines.
In 2023 alone, an estimated 107,500 people died from measles, most of them children under the age of five, highlighting the consequences of gaps in immunization programmes.
Symptoms of measles typically appear 10 to 14 days after exposure. Early signs often resemble a common viral illness and can last up to a week. These include a runny nose, persistent cough, fever, red and watery eyes, and tiny white spots inside the mouth known as Koplik spots.
The most recognizable symptom—a red, blotchy rash—usually appears 7 to 18 days after exposure. It starts on the face and upper neck before spreading downward to the torso, arms, legs, hands and feet over several days. The rash generally lasts five to six days before fading.
Health officials in Mongolia emphasize that measles outbreaks are preventable. They urge parents, caregivers and schools to prioritize full vaccination and seek medical advice at the first sign of symptoms.
With measles capable of spreading rapidly through communities, authorities warn that completing both vaccine doses is not optional but essential to protecting children and preventing future outbreaks.
Credit: Canva
Extreme frigid temperatures have led to the death of 18 people across New York, Mayor Zohran Mamdani has confirmed.
Since late January, the city has been gripped in a cold snap, including 13 days of temperatures of 0C (32F) or below, one of the longest stretches of sub-zero weather New York has seen in six decades since a major snowstorm.
According to Mamdani, certain days in New York have been colder than the continent of Antarctica.
"Since Friday's press conference, one additional New Yorker lost their life on the streets of our city as a result of this cold snap. The total lives lost is now 18. Each life lost is a tragedy, and we will continue to hold their families in our thoughts," he said.
He also urged those experiencing homelessness to head to a shelter one of the 1,400 placements that have been made into shelters and safe havens. Apart from this, 33 New Yorkers have also been involuntarily transported for their safety in these conditions.
"Until temperatures warm up, I ask all of you in this room and outside of it to please continue to take additional precautions. Stay safe, stay indoors, and please, New York, let's keep looking out for one another," the mayor said.
The newly minted Mayor also said that across this past Friday and Saturday nights, 560 New Yorkers used Health + Hospitals warming centers and nearly 300 New Yorkers used a Department of Social Services warming vehicle.
READ MORE: US Cardiologist Reveals When You Are More Prone To Heart Attacks
On 27 January, Mamdani noted that at least 10 of the people who had died were found outdoors. The cause behind the other deaths remain known.
"We have been working hard to keep New Yorkers safe, and we will continue to do so. Because it is not forecast to be above 32 degrees [Fahrenheit] until tomorrow, and 35 degrees is hardly balmy weather," he said.
Winter is usually associated with hot drinks, cozy layers and fewer reminders to sip water. According to Dr. Swadesh Kumar, Cluster Head – Emergency and Trauma Care & Casualty, Gurugram, this mindset is exactly where the problem begins.
“People assume that because they’re not sweating or feeling thirsty, their body doesn’t need as much water. That’s a misconception,” he told Healthandme.
During cold spells, thirst signals are naturally suppressed. At the same time, the body continues to lose fluids through dry air, indoor heating and even breathing. “The loss is gradual and silent, which makes winter dehydration harder to spot,” Dr Kumar added.
Low fluid intake doesn’t just cause weakness, it can aggravate underlying health problems. When the body is dehydrated, blood becomes thicker, increasing the risk of clot formation. This is particularly dangerous for older adults and people with heart disease.
Kidneys are also affected. Reduced hydration puts extra strain on them, sometimes leading to acute kidney injury. “We see patients with palpitations, fainting spells and extreme weakness, only to later realize dehydration is the root cause,” Dr Kumar notes.
Winter illnesses further complicate the situation. Fever, rapid breathing and certain medications increase fluid loss. Yet many people intentionally avoid drinking water to reduce bathroom visits in the cold.
“This combination is especially risky for children and the elderly,” Dr. Kumar says. Children depend on caregivers for hydration reminders, while older adults naturally feel less thirsty. Both groups can slip into dehydration quickly during winter infections.
Doctors advise treating hydration as a routine, not a response to thirst. Warm water, soups, stews and herbal drinks are practical winter options. Fruits with high water content also help, even when appetite is low.
“Monitor urine color, limit excess caffeine and be extra careful if you have a chronic condition,” Dr Kumar advises.
The cold wave is a reminder that dehydration isn’t just a summer problem. Even in winter, the body needs adequate water to function, and ignoring that need can quietly turn into a medical emergency.
© 2024 Bennett, Coleman & Company Limited